Follow the people · Insider
James Woodruff Lillie
James Woodruff Lillie files insider transactions with the SEC as a chief scientific officer of MapLight Therapeutics (MPLT). We hold 10 disclosed purchases and sales filed since 6 March 2018, 4 of them in the last 90 days.
- Files forMPLT
- Disclosed buys and sells10 in all, 4 in the last 90 days
- Last disclosure19 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 27 October 2025 — 17 August 2026Chief Scientific Officer · MapLight Therapeutics (MPLT)30 Form 4 lines · source: SEC Form 4
- Filed 10 May 2018 — 10 May 2018Chief Scientific Officer · Millendo Therapeutics (MLND)1 Form 4 line · source: SEC Form 4
- Filed 6 March 2018 — 6 March 2018Chief Scientific Officer · OvaScience (OVAS)1 Form 4 line · source: SEC Form 4
Everything they disclosed
32 entries, newest first — one per disclosure report, one per Form 4 line- was granted 7,730 shares of MapLight TherapeuticsSEC Form 419 August 2026Voting Common Stock · traded 17 August 2026 · filed 19 August 2026
- was granted 31,395 shares of MapLight Therapeutics (a derivative holding)SEC Form 419 August 2026Employee Stock Option (right to buy) · traded 17 August 2026 · filed 19 August 2026
- ▼ sold on the open market 22,082 shares of MapLight TherapeuticsSEC Form 44 August 2026Voting Common Stock · traded 3 August 2026 · filed 4 August 2026
- ▼ sold on the open market 2,238 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 5,393 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 12 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 5,009 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 3,526 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 12 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 2,077 shares of MapLight TherapeuticsSEC Form 417 July 2026Voting Common Stock · traded 17 July 2026 · filed 17 July 2026
- ▼ sold on the open market 721 shares of MapLight TherapeuticsSEC Form 411 May 2026Voting Common Stock · traded 7 May 2026 · filed 11 May 2026
- ▼ sold on the open market 9,250 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 5,526 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 320 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 705 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 10,132 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 5 May 2026 · filed 6 May 2026
- ▼ sold on the open market 963 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 5 May 2026 · filed 6 May 2026
- ▼ sold on the open market 8,390 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 6 May 2026 · filed 6 May 2026
- ▼ sold on the open market 16,421 shares of MapLight TherapeuticsSEC Form 46 May 2026Voting Common Stock · traded 6 May 2026 · filed 6 May 2026
- ▼ sold on the open market 1,730 shares of MapLight TherapeuticsSEC Form 417 April 2026Voting Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 686 shares of MapLight TherapeuticsSEC Form 417 April 2026Voting Common Stock · traded 16 April 2026 · filed 17 April 2026
- ▼ sold on the open market 2,097 shares of MapLight TherapeuticsSEC Form 417 April 2026Voting Common Stock · traded 16 April 2026 · filed 17 April 2026
- was granted 7,730 shares of MapLight TherapeuticsSEC Form 49 February 2026Voting Common Stock · traded 5 February 2026 · filed 9 February 2026
- was granted 31,395 shares of MapLight Therapeutics (a derivative holding)SEC Form 49 February 2026Employee Stock Option (right to buy) · traded 5 February 2026 · filed 9 February 2026
- was granted 31,395 shares of MapLight Therapeutics (a derivative holding)SEC Form 49 February 2026Employee Stock Option (right to buy) · traded 5 February 2026 · filed 9 February 2026
- was granted 7,730 shares of MapLight TherapeuticsSEC Form 49 February 2026Voting Common Stock · traded 5 February 2026 · filed 9 February 2026
- had shares withheld for tax on 45,055 shares of MapLight TherapeuticsSEC Form 429 January 2026Voting Common Stock · traded 27 January 2026 · filed 29 January 2026
- had shares withheld for tax on 45,055 shares of MapLight TherapeuticsSEC Form 429 January 2026Voting Common Stock · traded 27 January 2026 · filed 29 January 2026
- was granted 132,023 shares of MapLight Therapeutics (a derivative holding)SEC Form 428 October 2025Employee Stock Option (right to buy) · traded 27 October 2025 · filed 28 October 2025
- was granted 32,539 shares of MapLight TherapeuticsSEC Form 428 October 2025Voting Common Stock · traded 27 October 2025 · filed 28 October 2025
- was granted 8,333 shares of Millendo Therapeutics (a derivative holding)SEC Form 411 December 2018Employee Stock Option (right to buy) · traded 10 May 2018 · filed 11 December 2018
- was granted 357,057 shares of OvaScience (a derivative holding)SEC Form 46 March 2018Stock Option (right to buy) · traded 6 March 2018 · filed 6 March 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.